12th Sep 2023 A plain language summary describing the effect of rapidly rising prostate-specific antigen (PSA) levels on how long men with a type of advanced prostate cancer live and their healthcare costs
10th Aug 2023 A plain language summary looking at whether declines in prostate-specific antigen level indicates how long patients with advanced prostate cancer will live when treated with enzalutamide
20th May 2022 Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer